Library
阿托品
Atropine is classified as Deliriant anticholinergic. It belongs to the Tropane alkaloid (belladonna alkaloid) chemical class.
Also known as: 口服阿托品, 托品酸托品, Dl-甲酰托品酸, 阿托品, 阿托品, 阿托品铵
Classification
- Chemical: Tropane
Effects
- Dry Mouth
- Tachycardia And Palpitations
- Urinary Retention And Constipation
- Restlessness
- Sedation
- Increased Heart Rate
- Agitation
- Confusion
- Memory Impairment
- Paranoia
- Increased Focus
- Talkativeness
- Open Eye Visuals
- Light Sensitivity
- Disinhibition
- Dehydration
- Appetite Suppression
- Increased Libido
Routes of Administration
Oral
Dosage
- Heavy: 10+ mg (often toxic)
- Light: 0.5 – 1 mg
- Common: 2 – 5 mg
- Strong: 6 – 10 mg
- Threshold: 0.3 mg
Duration
- Onset: 0.5-1 h
- Peak: 1-3 h
- Offset: 4-8 h
- After Effects: 24-72 h
- Total Duration: 6-12 h
Intravenous
Dosage
- Heavy: 2+ mg (poisoning risk)
- Light: 0.3 – 0.6 mg
- Common: 0.6 – 1 mg
- Strong: 1 – 2 mg
- Threshold: 0.2 mg (therapeutic)
Duration
- Onset: 0.02-0.07 h
- Peak: 0.25-0.5 h
- Offset: 4-8 h
- After Effects: 24-48 h
- Total Duration: 4-8 h
Ophthalmic
Dosage
- Heavy: Any non‑prescribed or ingested use = unsafe %
- Light: 0.01% %
- Common: 0.025–0.05% (clinical myopia control ranges) %
- Strong: 0.5–1% (cycloplegia/penalization; high adverse-effect burden) %
- Threshold: 0.005–0.01% (low-dose myopia control research) %
Duration
- Onset: 0.5-1 h
- Peak: 0.04-0.125 h
- Offset: 1-3 h
- After Effects: 3-20 h
- Total Duration: 1-14 h
Harm Reduction
Check interactions before mixing substances, pay attention to dose spacing and hydration, and treat all dosage guidance as approximate rather than guaranteed safe.
Sources
Substance data is aggregated from the following public harm-reduction and reference sources.
No external data sources listed for this substance yet.
Links
This static page is intended as a readable non-JS and prerender-friendly library export.
